Affiliations of authors: Department of Preventive Medicine (LB, GU, JS-H, DD), Department of Pathology (MFP), Keck School of Medicine, University of Southern California, Los Angeles, CA; Department of Nutrition, University of Oslo, Oslo, Norway (GU); Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA (AVP); Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ (JAB); Fred Hutchinson Cancer Research Center, Seattle, WA and Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA (JRD, KEM); Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA (JAM, SGF, PAM); Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA (SAN, BLS); School of Public Health, Emory University, Atlanta, GA (JL); Department of Internal Medicine, Karmanos Cancer Institute at Wayne State University, Detroit, MI (MSS); Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA (RTB); Cancer Centers Branch, National Cancer Institute (LKW), Contraception and Reproductive Health Branch, Center for Population Research, National Institute of Child Health and Human Development (RS), National Institutes of Health, Bethesda, MD
Correspondence to: Leslie Bernstein, PhD, Department of Preventive Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave., Los Angeles, CA 90033 (e-mail: lbern{at}usc.edu).
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
What remains unclear is the amount of lifetime activity necessary to reduce risk (if the association is causal), whether the benefits of activity vary by age, and whether the reduction in risk is observed in all population subgroups. For example, only one study has addressed the issue of physical activity in relation to breast cancer among black women, a casecontrol study of prevalent breast cancers nested within a cohort of black women (11). Results of another study suggested that physical activity has less benefit for women with a family history of breast cancer (12). To understand the association between physical activity and breast cancer risk better, we examined the relationship between lifetime and time- or age-specific measures of recreational exercise activity and breast cancer risk among white women and black women, and among women with and without a family history of breast cancer, in a large multicenter, population-based casecontrol study. We also evaluated whether the relationship was modified by any other breast cancer risk factors or by tumor characteristics.
![]() |
PARTICIPANTS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The Women's Contraceptive and Reproductive Experiences Study is a population-based casecontrol study that was designed to examine predictors of risk for invasive breast cancer among white women and black women. Five sites participated in this study: Atlanta, Detroit, Los Angeles, Philadelphia, and Seattle. All study participants were white (including Hispanics) or black, English speaking, U.S. born, and aged 3564 years, with no previous diagnosis of in situ or invasive breast cancer. A full description of the study methods, including extensive details on subject identification, recruitment, and participation rates, has been previously provided (13).
Case patients were women diagnosed with histologically confirmed invasive breast cancer [International Classification of Diseases for Oncology codes C50.0C50.9 (14)] between July 1, 1994, and April 30, 1998. In Atlanta, Detroit, Los Angeles, and Seattle, these patients were identified by the Surveillance, Epidemiology and End Results (SEER) cancer registries. In Philadelphia, patients were identified by field staff who contacted hospitals in the study area. Black women were oversampled to maximize their numbers in the study, and white women were randomly sampled to provide approximately equal numbers of women in each 5-year age category (3539, 4044, 4549, 5054, 5559, and 6064 years). Of the 5982 eligible case patients identified, we interviewed 4575 (76.5%), including 2953 white women (79.1% of eligible case patients) and 1622 black women (72.2% of eligible case patients). Of those eligible case patients who were not interviewed, 523 (8.7%) refused to participate; physicians refused permission to contact 235 (3.9%); we were unable to schedule an interview within the appropriate time frame (within 18 months of diagnosis or prior to study end date) or could not locate the patient for 395 (6.6%); 149 (2.5%) died before interview; and a variety of reasons accounted for the remaining 105 (1.8%) who were not interviewed. We extracted stage of breast cancer at diagnosis and estrogen receptor (ER) status from SEER registry records at the four SEER sites and from medical records in Philadelphia.
Random-digit dialing methods were used to identify control subjects from the geographic regions of corresponding case patients. During screening telephone calls, a census of potentially eligible women was created for each household contacted. Control subjects were randomly selected from the pool of women identified and were frequency-matched to case patients within strata of geographic site, race, and 5-year age group. Approximately 82% of residential households contacted were successfully screened. Of the 5956 eligible women (2212 black women and 3744 white women) who were selected as control subjects, 4682 (78.6%) were interviewed; 3021 (80.7%) were white and 1661 (75.1%) were black. Among eligible women we attempted to recruit, 774 (13.0%) refused to participate; we could not schedule an interview within the appropriate time frame (within 18 months of initial telephone contact with the household or prior to study end date) or were unable to locate 352 (5.9%); and we were unable to interview 148 (2.5%) for a variety of reasons.
Eligible subjects were first contacted by letter and then by telephone to schedule an in-person interview. During the telephone contact, standardized questions were asked by the interviewers to establish eligibility. All participants provided written informed consent before the in-person interview. The study was approved by the institutional review board at each institution involved in this collaborative study, in accord with assurances filed with and approved by the U.S. Department of Health and Human Services.
Information was collected during the interview up to a reference date that was defined for each case patient as the date of diagnosis and for each control subject as the date of contact with the household during the random-digit dialing screening process. Study subjects provided information on demographic and reproductive factors, including ages at menarche, menopause, and all pregnancies; pregnancy outcomes; lactation history; use of oral contraceptives and hormonal therapies; type of menopause if postmenopausal; family history of breast cancer; body size measures; lifestyle (history of exercise activity, smoking, and alcohol consumption); and frequency of mammographic screening in the 5 years before the reference date. Each participant was required to have a working residential telephone on her reference date and to be interviewed within 18 months of her reference date; 77% of interviewed case patients and 88% of interviewed control subjects were interviewed within 6 months of their reference dates.
We excluded nine case patients and four control subjects for whom information on exercise activity was missing and 28 case patients and 29 control subjects for whom information was missing for at least one of the following items: age at menarche, age at first term pregnancy (>26 weeks), total number of term pregnancies, total months of breast-feeding, or body mass index [weight in kilograms/(height in meters)2] 5 years before the reference date. A total of 4538 case patients and 4649 control subjects were included in our analyses.
Measures of Exercise Activity
Recreational exercise activity was recorded after completion of a calendar of life events, on which we had recorded all pregnancy and contraception information. We documented all episodes of exercise activity in which a participant engaged throughout her lifetime up to her reference date and recorded details of activities in chronologic order starting with the first activity recalled by the respondent. For each activity episode, we recorded the type of activity, the age at which the woman started and stopped the activity, the number of months per year of participation in the activity, and the average duration in hours per week. Initially, women were instructed to report only those exercise activities in which they engaged at least 2 hours/week for at least 4 months. After completing interviews with 385 case patients and 488 control subjects, we changed this instruction so that women would include activities in which they engaged at least 1 hour/week for at least 4 months at any given age (4153 case patients and 4161 control subjects). We recorded all activities that women provided including any organized sports activities, such as school sports or teams, and individual activities, such as walking, jogging, running, hiking, bicycling, aerobics, swimming, and dancing. We also recorded details as to the extent of the activity (for example, recreational swimming, snorkeling, swimming laps, or training for competitive swimming).
We calculated the average number of hours of exercise activity per week for each year of age for each participant. We considered women to be inactive at any given age if they reported no activity for that age or if their average number of hours per week of activity for that age was less than 0.67 hour (i.e., equivalent to less than 2 hours/wk for 4 months). We then estimated the metabolic equivalents of energy expenditure (MET)-hours per week for each age by multiplying together the number of hours per week a woman spent in a particular activity, the proportion of the year spent in that activity, and the estimated MET score for the activity based on the Compendium of Physical Activities (15). As a measure of lifetime activity, we calculated average annual exercise activity from age 10 years to the woman's age on her reference date in hours per week and in MET-hours per week. We also calculated the average number of hours per week and the average number of MET-hours per week for the following times: ages 1019 years, the first 10 years after menarche, ages 2034 years, and the 10 years before a woman's reference date. For variables representing average hours per week and average MET-hours per week of exercise activity, we categorized women by approximate quartiles of the distribution of all control subjects classified as active.
Statistical Analyses
We used unconditional logistic regression modeling (16) to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs) to examine the relationship between measures of exercise activity and breast cancer risk. Women who were classified as inactive at all ages were used as the referent group. For each analysis, we assessed risk associated with exercise activity in two models. In the first model, we adjusted for age (continuous), race (white or black), study site (Atlanta, Detroit, Los Angeles, Philadelphia, or Seattle), and type of questionnaire on exercise activity (original or modified). In the second model, we adjusted for these variables as well as for potential confounding factors that were selected a priori because of their fairly well-established relationship with breast cancer risk.
The potential confounding factors included in the multivariable models were family history of breast cancer in mother, sisters, or daughters (first-degree family history: yes, no, or unknown/adopted); age at menarche (continuous); body mass index at 5 years before the reference date (continuous); age at menopause (premenopausal, ages <35, 3539, 4044, 4549, 5054, or 55 years, or menopausal status not able to be determined or age unknown); number of term pregnancies (continuous); age at first term pregnancy (ages <20, 2024, 2529, 3034, or
35 years or nulliparous); and total months of breast feeding (continuous). A woman was considered postmenopausal if, before her reference date, she had experienced a final menstrual period followed by a 12-month period with no menstrual period and no hormonal therapy (natural menopause), if she reported a bilateral oophorectomy (surgical menopause), or if her menstrual periods stopped because of radiation or chemotherapy at least 12 months before her reference date. We considered a woman to be premenopausal if she had any menstrual periods during the 12 months before her reference date and if she was not taking hormone replacement therapy. We were unable to determine menopausal status for women who had a hysterectomy and no bilateral oophorectomy when still having menstrual periods or within 12 months of their last menstrual period and women who began hormonal therapy while still menstruating or within 12 months of the last menstrual period.
Trend tests for each exercise activity variable were performed by fitting the median value of exercise activity within each of the categories as a continuous variable. When examining exercise activity trends during a specific time period, women who engaged in exercise activity only in other time periods were not included in the trend models so that the reference group was restricted to women considered to have no lifetime activity. To test whether the association between exercise activity and breast cancer risk was modified by other factors, we used a likelihood ratio test comparing two multivariable logistic regression models. We examined effect modification by age (<50 years versus 50 years), race (black versus white), first-degree family history of breast cancer (yes versus no, excluding those with unknown status), parity (nulliparous versus parous women), body mass index (<25 kg/m2 versus
25 kg/m2), menopausal status (premenopausal versus postmenopausal, excluding those with unknown menopausal status), ever used oral contraceptives (no versus yes), and ever used any type of hormone replacement therapy among postmenopausal women (no versus yes). The base model, which included one variable for exercise activity trend, was compared with a model with two variables for exercise activity trend, one for each of the two categories of the potential effect modifier (likelihood ratio test for heterogeneity of trends with 1 df) (17). We also examined risk by stage of disease (local versus nonlocal) and ER status (ER-negative versus ER-positive tumors) by comparing each subgroup with all control subjects and then conducting an analysis restricted to case patients. For subgroup analysis, we present only the results from fully adjusted models. All P values reported are from tests of two-sided alternative hypotheses. We did not adjust for multiple comparisons.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Black women were more likely than white women to be classified as inactive (Table 3). Among 4538 case patients, 542 (33.8%) of the 1605 black women but only 590 (20.1%) of the 2933 white women were inactive. Among the 4649 control subjects, 535 (32.5%) of the 1646 black control subjects and 548 (18.2%) of the 3003 white control subjects were inactive. We observed no statistically significant inverse trends in breast cancer risk with an increasing level of lifetime exercise activity for white women (for average annual hours per week, Ptrend = .16; and for average annual MET-hours per week, Ptrend = .09), although the risk estimates for each exercise category were all below 1.0 and the confidence intervals for three of the four activity categories excluded 1.0 (Table 3). For black women, we observed a statistically significant inverse association with increasing level of lifetime exercise activity (for average annual hours per week, Ptrend = .002; and for average annual MET-hours per week, Ptrend = .003). Nevertheless, we observed no effect modification by race (for average annual hours per week, heterogeneity of trends P = .08; and for average annual MET-hours per week, P = .15).
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
All specific age and time periods of exercise activity examined were associated with reduced risks similar to that associated with average lifetime activity, so we were unable to identify an age or time of life when exercise activity had the greatest association with breast cancer risk. One reason we could not identify a time period when it would be most important to be physically active is because our lifetime activity measures are highly correlated with each of the age and time period measures and with each other. For example, Pearson correlation coefficients for our lifetime measures and our age- or time-specific measures ranged from .76 to .92 overall and for case patients and control subjects separately; similarly, the correlation coefficient between activity from ages 10 to 19 years and from ages 20 to 34 years was .60. The high correlations we observed confirm results reported by Alfano et al. (27), who showed that women who are physically active during childhood and adolescence are more likely to be physically active as adults. Our results were remarkably similar for both metrics of activityhours per week and MET-hours per weekand are also similar to those of Bernstein et al. (28), who reported results for hours per week only, but noted that results for MET-hours per week were comparable.
We evaluated whether body mass index modified the association between exercise activity and breast cancer risk and found no evidence of any interaction, overall or by menopausal status. Several previous studies suggested modification of the association between physical activity and breast cancer by body mass index, although the body mass index subgroups for which the associations were strongest are not consistent across studies (12,23,25,2931).
Various biologic mechanisms have been proposed through which physical activity could, in theory, reduce the risk of breast cancer. Studies among athletes show that high levels of moderate and vigorous physical activity during the reproductive years affect markers of exposure to ovarian hormones, resulting in delayed menarche, increased likelihood of secondary amenorrhea, irregular or anovulatory menstrual cycles, and shortened luteal phases of the menstrual cycle (2,28,3235). Thus, physical activity is associated with lower concentrations of estradiol, progesterone, and follicle-stimulating hormone circulating in the blood, particularly during adolescence. Additional studies (4,5) suggest that ovarian function may be altered in recreational athletes who engage in less strenuous activity, through lower mean concentrations of hormones or longer menstrual cycles, although data are not as conclusive as those for athletes with higher levels of physical activity. Women who are physically active during the postmenopausal years have lower concentrations of serum estrone (3,6), estradiol (3,36), and androgens (androstenedione and testosterone), which are precursors to estrogens (3,6), than inactive women. An association between physical activity and higher concentrations of sex hormone-binding globulin has also been observed (8).
In addition, regular physical activity has been associated with higher insulin sensitivity and lower concentrations of serum insulin (8,37). Higher concentrations of insulin have been associated with lower concentrations of sex hormonebinding globulin and, consequently, higher concentrations of bioavailable or free estradiol, which may increase breast cancer risk (38). High levels of physical activity have been most consistently associated with lower weight, lower body mass index, and weight loss (69,39). Maintenance of normal body weight is one of the few known ways to modify risk for breast cancer, and a lack of energy balance that results in excess adipose tissue is associated with many other potential mechanisms and risk factors for breast cancer such as insulin resistance (40,41) and higher concentrations of insulin-like growth factors (41), total estradiol (via increased aromatase activity) (42), and free estradiol (resulting from lower concentrations of sex hormonebinding globulin) (8,42). Thus, the associations between physical activity and breast cancer risk may be due to the direct suppression of hormone concentrations or may be more indirect.
Family history of breast cancer may modify the association between exercise activity and breast cancer risk, because we observed no reduction in risk among women reporting a first-degree family history of breast cancer. However, it should be noted that only among women in the highest exercise activity categories (either 3 hours/wk/y or
15.2 MET-hours/week/year) was a difference in breast cancer risk by family history observed. For other categories of exercise activity, the risk for women with a family history was similar to that for women without such a history. Several other studies have examined how a family history of breast cancer modifies the association between exercise activity and breast cancer (12,4349). One study reported that family history modified the association between physical activity and breast cancer among postmenopausal women, with statistically significant trends in risk observed only among women with no family history of breast cancer (12). The majority of women in this previous study were white. Hormonal differences by family history offer one possible explanation for the variation in risk by family history. Serum concentrations of estrone and estradiol have been shown to be higher in premenopausal women with a family history of breast cancer than in age-matched control subjects (50). Therefore, it is biologically plausible that the impact of breast cancer risk factors mediated through hormonal pathways, such as physical activity, may differ by family history.
We evaluated whether the association between physical activity and breast cancer risk differed by ER status. Our results for ER-positive tumors did not differ from those for ER-negative tumors. Enger et al. (51) reported results on tumor receptor status from two casecontrol studies of breast cancer. In these studies, the risk for ER-positive/progesterone (PR)-positive, ER-positive/PR-negative, and ER-negative/PR-negative breast cancers decreased with increasing levels of physical activity.
Our study has several strengths, as well as several potential limitations. Among the strengths are the study's size, population-based sampling, geographic diversity, and inclusion of both black and white women. The detailed data that we obtained on exercise activity, by use of the calendar of life events to facilitate recall, permitted assessment of lifetime exercise activity, as well as activity during various age and time periods. This interview approach, known as cognitive interviewing, has proved to be a reliable method for collecting lifetime histories of exercise activity (52). Further, this systematic method of collecting information on lifetime exercise should reduce the likelihood of biased reporting. Any misclassification is likely to be nondifferential, so that the associations we have found may be underestimates of the real associations.
A potential limitation for any casecontrol study is the possibility that selection bias or recall bias may have influenced the results. In regard to selection bias, we note that our response rates were relatively high and the findings for exercise activity were consistent across study sites. For example, the test for heterogeneity of trends in breast cancer risk associated with hours per week of exercise activity across the five study sites yielded a P value of .20. Recall bias was minimized by assessing exercise activity in conjunction with the completion of a calendar of life events to facilitate recall and by recording activities at every age throughout life. Nevertheless, recall bias cannot be ruled out in our study. A further limitation of our study is the lack of information on occupational and household activity. A study of women in Alberta, Canada, found no impact of recreational activity on breast cancer risk, but a statistically significant inverse association with occupational and household activity (49).
In summary, this study further substantiates the association between physical activity and breast cancer risk. Our data suggest that regular exercise activity throughout a woman's life can decrease breast cancer risk and that the association of physical activity and breast cancer risk is not materially modified by race. This study provides evidence of a reduction in risk among black women living in five geographic areas of the United States. The inverse association between physical activity and breast cancer risk may be more pronounced in women with no family history of breast cancer. We were not able to identify critical time periods in a woman's life when exercise is most beneficial, and we could not determine which activities or intensity of activities confer the greatest risk reduction.
![]() |
NOTES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Supported by the National Institute of Child Health and Human Development, with additional support from the National Cancer Institute, through contracts with Emory University (N01 HD 3-3168), the Fred Hutchinson Cancer Research Center (N01 HD 2-3166), the Karmanos Cancer Institute at Wayne State University (N01 HD 3-3174), the University of Pennsylvania (N01 HD 3-3176) and the University of Southern California (N01 HD 3-3175), and through an intra agency agreement with the Centers for Disease Control and Prevention (Y01 HD 7022). General support through SEER contract numbers N01-PC-67006 (Atlanta), N01-CN-65064 (Detroit), N01-CN-67010 (Los Angeles), and N01-CN-0532 (Seattle) is also acknowledged. The collection of cancer incidence data for Los Angeles County used in this publication was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by the California Health and Safety Code Section 103885. The ideas and opinions expressed herein are those of the authors, and no endorsement by the State of California, Department of Health Services, is intended or should be inferred.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
(1) Bernstein L, Ross RK, Lobo RA, Hanisch R, Krailo MD, Henderson BE. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer 1987;55:6815.[ISI][Medline]
(2) Bonen A, Belcastro AN, Ling WY, Simpson AA. Profiles of selected hormones during menstrual cycles of teenage athletes. J Appl Physiol 1981;50:54551.
(3) Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:112031.[Abstract]
(4) Broocks A, Pirke KM, Schweeiger U, Tuschl RJ, Laessle RG, Strowitzki T, et al. Cyclic ovarian function in recreational athletes. J Appl Physiol 1990;68:20836.
(5) Cooper GS, Sandler DP, Whelan EA, Smith KR. Association of physical and behavioral characteristics with menstrual cycle patterns in women age 2931 years. Epidemiology 1996;7:6248.[ISI][Medline]
(6) Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ. Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab 1988;66:92733.[Abstract]
(7) Thune I, Njolstad I, Lochen ML, Forde OH. Physical activity improves the metabolic risk profiles in men and women. Arch Intern Med 1998;158:163340.
(8) Tymchuk CN, Tessler SB, Barnard RJ. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise. Nutr Cancer 2000;38:15862.[CrossRef][ISI][Medline]
(9) Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001;12:4759.[CrossRef][ISI][Medline]
(10) Vainio H, Bianchini F, editors. IARC handbooks on cancer prevention: weight control and physical activity. Lyon (France): IARC Press; 2002.
(11) Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR. Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc 2001;93:26775.[ISI][Medline]
(12) Carpenter C, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity, and exercise on breast cancer risk among postmenopausal women. Int J Cancer 2003;106:96102.[CrossRef][ISI][Medline]
(13) Marchbanks PA, McDonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 2002;12:21321.[CrossRef][ISI][Medline]
(14) World Health Organization. International classification of diseases for oncology. 2nd ed. Geneva (Switzerland): WHO; 1990.
(15) Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498504.[CrossRef][ISI][Medline]
(16) Kleinbaum DG. Logistic regression. New York (NY): Springer; 1994.
(17) Kleinbaum G, Kupper L, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York (NY): Van Nostrand Reinhold; 1982.
(18) Hu YH, Nagata C, Shimizu H, Kaneda N, Kashiki Y. Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat 1997;43:6572.[CrossRef][ISI][Medline]
(19) Ueji M, Ueno E, Osei-Hyiaman D, Takahashi H, Kano K. Physical activity and the risk of breast cancer: a case-control study of Japanese women. J Epidemiol 1998;8:11622.[Medline]
(20) Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM. Physical activity and breast cancer risk in Hispanic and non-Hispanic white women. Am J Epidemiol 2001;154:44250.
(21) Matthews CE, Shu XO, Jin F, Dai Q, Herbert JR, Ruan ZX, et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 2001;84:9941001.[CrossRef][ISI][Medline]
(22) Yang D, Bernstein L, Wu AH. Physical activity and breast cancer risk among Asian-American women in Los Angeles. Cancer 2003;97:256575.[CrossRef][ISI][Medline]
(23) Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:126975.
(24) Dirx MJM, Voorrips LE, Goldbohm RA, van den Brant PA. Baseline recreational physical activity, history of sports participation, and postmenopausal breast carcinoma risk in the Netherlands Cohort Study. Cancer 2001;92:163849.[CrossRef][ISI][Medline]
(25) Moradi T, Adami H, Ekbom A, Wedren S, Terry P, Floderus B, et al. Physical activity and risk for breast cancer: a prospective cohort study among Swedish twins. Int J Cancer 2002;100:7681.[CrossRef][ISI][Medline]
(26) Steindorf K, Schmidt M, Kropp S, Chang-Claude J. Case-control study of physical activity and breast cancer risk among premenopausal women in Germany. Am J Epidemiol 2003;157:12130.
(27) Alfano CM, Klesges RC, Murray DM, Beech BM, McClanahan BS. History of sport participation in relation to obesity and related health behaviors in women. Prev Med 2002;34:829.[CrossRef][ISI][Medline]
(28) Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 1994;86:14038.[Abstract]
(29) Colditz GA, Feskanich D, Chen WY, Hunter DJ, Willett WC. Physical activity and risk of breast cancer in premenopausal women. Br J Cancer 2003;89:84751.[CrossRef][ISI][Medline]
(30) Hirose K, Hamajima N, Takezaki T, Miura S, Tajima K. Physical activity reduces risk of breast cancer in Japanese women. Cancer Sci 2003;94:1939.
(31) McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: The Women's Health Initiative Cohort Study. JAMA 2003;290:13316.
(32) Shangold M, Freeman R, Thysen B, Gatz M. The relationship between long-distance running, plasma progesterone, and luteal phase length. Fertil Steril 1979;31:1303.[ISI][Medline]
(33) Warren M. The effects of exercise on pubertal progression and reproductive function in girls. J Clin Endocrinol Metab 1980;51:11507.[Abstract]
(34) Frisch RE, Gotz-Welbergen AV, McArthur JW, Albright T, Witschi J, Bullen B, et al. Delayed menarche and amenorrhea of college athletes in relation to age at onset of training. JAMA 1981;246:155963.[Abstract]
(35) Ellison PT, Lager C. Moderate recreational running is associated with lowered salivary progesterone profiles in women. Am J Obstet Gynecol 1986;154:10003.[ISI][Medline]
(36) Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Relations of insulin resistance and serum concentrations of estradiol and sex hormone-binding globulin to potential breast cancer risk factors. Jpn J Cancer Res 2000;91:94853.[ISI][Medline]
(37) Helmrich SP, Ragland DR, Leung RW. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991;325:14752.[Abstract]
(38) Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:839.[Abstract]
(39) Blair SN. Evidence for success of exercise in weight loss and control. Ann Intern Med 1993;119:7026.
(40) Bruning PF, Bonfree JB, vanNoord PA, deJong-Bakker M, Nooijen WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992;52:5116.[ISI][Medline]
(41) Ballard-Barbash R. Perspectives on integrating experimental and epidemiologic research on diet, anthropometry, and breast cancer. J Nutr 1997;127 (5 Suppl):936S-9S.[Medline]
(42) Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:1735.[ISI][Medline]
(43) McTiernan A, Stanford JL, Weiss NS, Daling JR, Voigt LF. Occurrence of breast cancer in relation to recreational exercise in women age 5064 years. Epidemiology 1996;7:598604.[ISI][Medline]
(44) Chen CL, White E, Malone KE, Daling JR. Leisure-time physical activity in relation to breast cancer among young women (Washington, United States). Cancer Causes Control 1997;8:7784.[CrossRef][ISI][Medline]
(45) Gammon MD, Schoenberg JB, Britton JA, Kelsey JL, Coates RJ, Brogan D, et al. Recreational physical activity and breast cancer risk among women under age 45. Am J Epidemiol 1998;147:27380.[Abstract]
(46) Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Colditz GA. A prospective study of recreational physical activity and breast cancer risk. Arch Intern Med 1999;159:22906.
(47) Moore DB, Folsom AR, Mink PJ, Hong CP, Anderson KE, Kushi LH. Physical activity and incidence of postmenopausal breast cancer. Epidemiology 2000;11:2926.[CrossRef][ISI][Medline]
(48) Verloop J, Rookus MA, van der Kooy K, van Leeuwen FE. Physical activity and breast cancer risk in women aged 2054 years. J Natl Cancer Inst 2000;92:12835.
(49) Friedenreich CM, Bryant HE, Courneya KS. Case-control study of lifetime physical activity and breast cancer risk. Am J Epidemiol 2001;154:33647.
(50) Henderson BE, Gerkins V, Rosario I, Casagrande J, Pike MC. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 1975;293:7905.[Abstract]
(51) Enger SM, Ross RK, Paganini-HIll A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000;9:6817.
(52) Friedenreich CM, Courneya KS, Bryant HE. The lifetime total physical activity questionnaire: development and reliability. Med Sci Sports Exerc 1998;30:26674.[ISI][Medline]
Manuscript received April 12, 2005; revised September 7, 2005; accepted September 22, 2005.
![]() |
||||
|
Oxford University Press Privacy Policy and Legal Statement |